SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Ripple Erik Spencer

(Last)

(First)

(Middle)

C/O INGEVITY CORPORATION

4920 O'HEAR AVE, SUITE 400

(Street)

NORTH CHARLESTON

29405

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
04/26/2022

3. Issuer Name and Ticker or Trading Symbol
Ingevity Corp [ NGVT ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Growth & Innov Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	11,473	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Employee Stock Option (Right to Buy)	⁽¹⁾	02/28/2028	Common Stock	834	$74.91	D
Employee Stock Option (Right to Buy)	⁽²⁾	02/28/2029	Common Stock	828	$115.22	D
Employee Stock Option (Right to Buy)	⁽³⁾	02/28/2030	Common Stock	1,575	$45.04	D
Employee Stock Option (Right to Buy)	⁽⁴⁾	02/26/2031	Common Stock	2,536	$69.48	D
Employee Stock Option (Right to Buy)	⁽⁵⁾	02/28/2032	Common Stock	3,407	$68.23	D

Explanation of Responses:

1. These options are granted pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan, as amended (the "OIP"), and became exercisable on February 28, 2021.

2. These options are granted pursuant to the OIP, and became exercisable ratably on February 28, 2020, 2021, and 2022.

3. These options are granted pursuant to the OIP. 787 options became exercisable on February 28, 2022, and the remaining 788 options will become exercisable on February 28, 2023.

4. These options are granted pursuant to the OIP. 846 options became exercisable on February 26, 2022. The remaining 1,690 options will become exercisable ratably on February 26, 2023 and 2024.

5. These options are granted pursuant to the OIP, and will become exercisable ratably on February 28, 2023, 2024, and 2025.

Remarks:

Exhibits: Exhibit 24 - Power of Attorney

	/s/ Erik Ripple By: Mavis Huger as Attorney-in-Fact	05/06/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.